Certain drugs are transformed into reactive metabolites by cytochrome P-450, a 
hepatic microsomal enzyme. The reactive metabolites covalently bind to 
hepatocyte macromolecules, thus determining liver lesions. Induction of 
microsomial enzymes increases the formation of reactive metabolites and 
exaggerates hepatotoxicity of these drugs.